|
Market Closed -
Other stock markets
|
After hours 20:58:49 | |||
| 2.830 EUR | -0.18% |
|
2.828 | -0.07% |
| 05-04 | Mubadala and Tubacex launch TBX Nexxia in Abu Dhabi | RE |
| 04-24 | Tubacex Q1 net profit at 1.3 mln euros | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -1.87 | 2.52 | 4.26 | 3.12 | 0.44 | |||||
Return on Total Capital | -2.46 | 3.58 | 6.4 | 4.41 | 0.58 | |||||
Return On Equity % | -14.22 | 8.76 | 15.03 | 6.51 | -5.41 | |||||
Return on Common Equity | -16.4 | 9.66 | 15.74 | 7.4 | -9.33 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 49.53 | 58.91 | 54.96 | 58.11 | 54.48 | |||||
SG&A Margin | 30.28 | 20.75 | 18.63 | 21.38 | 25.19 | |||||
EBITDA Margin % | 2.97 | 12.42 | 14.64 | 13.86 | 7.57 | |||||
EBITA Margin % | -6.94 | 7.18 | 10.33 | 9.47 | 2.82 | |||||
EBIT Margin % | -9.06 | 6.2 | 9.45 | 8.25 | 1.24 | |||||
Income From Continuing Operations Margin % | -11.33 | 3.21 | 5.01 | 3.28 | -3.28 | |||||
Net Income Margin % | -9.38 | 2.82 | 4.25 | 2.97 | -4.33 | |||||
Net Avail. For Common Margin % | -10.46 | 2.82 | 4.25 | 2.97 | -4.33 | |||||
Normalized Net Income Margin | -6.93 | 1.98 | 2.87 | 2.12 | -3.03 | |||||
Levered Free Cash Flow Margin | -6.39 | 6.13 | 3.78 | -16.1 | -9.45 | |||||
Unlevered Free Cash Flow Margin | -3.74 | 8.07 | 6.21 | -13.06 | -7 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.33 | 0.65 | 0.72 | 0.61 | 0.57 | |||||
Fixed Assets Turnover | 1.26 | 2.81 | 2.98 | 2.61 | 2.32 | |||||
Receivables Turnover (Average Receivables) | 4.81 | 8.24 | 10.45 | 10.22 | 9.61 | |||||
Inventory Turnover (Average Inventory) | 0.6 | 0.85 | 0.97 | 0.77 | 0.8 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.23 | 1.05 | 0.97 | 1.27 | 1.22 | |||||
Quick Ratio | 0.54 | 0.46 | 0.39 | 0.57 | 0.49 | |||||
Operating Cash Flow to Current Liabilities | -0.05 | 0.14 | 0.13 | -0.06 | -0.02 | |||||
Days Sales Outstanding (Average Receivables) | 75.88 | 44.29 | 34.91 | 35.83 | 37.97 | |||||
Days Outstanding Inventory (Average Inventory) | 607.39 | 428.32 | 374.38 | 473.07 | 454.33 | |||||
Average Days Payable Outstanding | 216.79 | 197.32 | 213.45 | 240.77 | 202.78 | |||||
Cash Conversion Cycle (Average Days) | 466.48 | 275.29 | 195.84 | 268.13 | 289.52 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 209.6 | 181.54 | 172.71 | 107.3 | 134.48 | |||||
Total Debt / Total Capital | 67.7 | 64.48 | 63.33 | 51.76 | 57.35 | |||||
LT Debt/Equity | 114.33 | 66.83 | 52.38 | 40.22 | 51.79 | |||||
Long-Term Debt / Total Capital | 36.93 | 23.74 | 19.21 | 19.4 | 22.08 | |||||
Total Liabilities / Total Assets | 76.08 | 76.19 | 75.76 | 63.82 | 67.62 | |||||
EBIT / Interest Expense | -2.14 | 2 | 2.43 | 1.69 | 0.31 | |||||
EBITDA / Interest Expense | 0.92 | 4.15 | 3.78 | 2.85 | 1.99 | |||||
(EBITDA - Capex) / Interest Expense | -0.34 | 3.27 | 2.08 | 1 | 0.14 | |||||
Total Debt / EBITDA | 38.96 | 5.43 | 4.05 | 4.84 | 9.39 | |||||
Net Debt / EBITDA | 27.16 | 3.51 | 2.6 | 2.6 | 6.58 | |||||
Total Debt / (EBITDA - Capex) | -104.06 | 6.88 | 7.37 | 13.84 | 137.27 | |||||
Net Debt / (EBITDA - Capex) | -72.56 | 4.45 | 4.74 | 7.44 | 96.23 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -25.84 | 108.85 | 19.09 | -9.84 | -6.15 | |||||
Gross Profit, 1 Yr. Growth % | -16.28 | 148.39 | 11.1 | -4.67 | -12 | |||||
EBITDA, 1 Yr. Growth % | -61.58 | 774.25 | 40.32 | -14.61 | -48.78 | |||||
EBITA, 1 Yr. Growth % | 149.83 | -315.93 | 71.37 | -17.33 | -72.02 | |||||
EBIT, 1 Yr. Growth % | 66.34 | -242.85 | 81.63 | -21.32 | -85.92 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 47.57 | -159.13 | 85.99 | -41.03 | -193.87 | |||||
Net Income, 1 Yr. Growth % | 27.3 | -162.82 | 79.56 | -37.1 | -236.86 | |||||
Normalized Net Income, 1 Yr. Growth % | 13.44 | -159.67 | 72.59 | -33.25 | -234.04 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 40.49 | -155.86 | 79.45 | -37.93 | -241.61 | |||||
Accounts Receivable, 1 Yr. Growth % | 46.46 | 5.13 | -16.83 | 3.22 | -3.64 | |||||
Inventory, 1 Yr. Growth % | 18.98 | 20.68 | 8.67 | 2.93 | -6.39 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -9.64 | -3.48 | 14.95 | 6.32 | 4.81 | |||||
Total Assets, 1 Yr. Growth % | 0.28 | 11.33 | 4.46 | 10.01 | -8.68 | |||||
Tangible Book Value, 1 Yr. Growth % | -33.5 | 28.54 | 19.03 | 104.19 | -31.77 | |||||
Common Equity, 1 Yr. Growth % | -18.04 | 12.19 | 8.38 | 57.48 | -22.67 | |||||
Cash From Operations, 1 Yr. Growth % | 171.01 | -466.19 | 4.04 | -137.08 | -59.82 | |||||
Capital Expenditures, 1 Yr. Growth % | -5.74 | 5.61 | 189.73 | 23.47 | -24.45 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 181.86 | -300.49 | -26.6 | -484.08 | -44.94 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -1.23K | -551 | -8.44 | -289.71 | -49.74 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | 87.4 | 72.46 | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -25.47 | 24.45 | 57.71 | 3.62 | -8.01 | |||||
Gross Profit, 2 Yr. CAGR % | -21.97 | 44.21 | 66.12 | 2.91 | -8.41 | |||||
EBITDA, 2 Yr. CAGR % | -55.94 | 83.26 | 250.25 | 9.46 | -33.87 | |||||
EBITA, 2 Yr. CAGR % | 20.86 | 132.26 | 92.36 | 19.03 | -51.9 | |||||
EBIT, 2 Yr. CAGR % | 66.92 | 54.15 | 61.08 | 19.54 | -66.72 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 62.89 | -6.59 | 4.87 | 4.73 | -25.6 | |||||
Net Income, 2 Yr. CAGR % | 69.98 | -10.58 | 6.2 | 6.28 | -7.22 | |||||
Normalized Net Income, 2 Yr. CAGR % | 137.42 | -17.73 | 1.48 | 7.33 | -5.41 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 86.59 | -11.41 | 0.12 | 5.09 | -6.25 | |||||
Accounts Receivable, 2 Yr. CAGR % | -2.49 | 24.09 | -6.49 | -7.35 | -0.27 | |||||
Inventory, 2 Yr. CAGR % | 1.39 | 19.83 | 14.52 | 5.76 | -1.84 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -4.75 | -6.61 | 8.67 | 6.79 | 5.62 | |||||
Total Assets, 2 Yr. CAGR % | -1.95 | 5.66 | 7.84 | 7.2 | 0.23 | |||||
Tangible Book Value, 2 Yr. CAGR % | -32.91 | -7.55 | 23.7 | 55.9 | 18.03 | |||||
Common Equity, 2 Yr. CAGR % | -17.13 | -4.11 | 10.27 | 30.65 | 10.35 | |||||
Cash From Operations, 2 Yr. CAGR % | -46.47 | 215.03 | 95.19 | -37.89 | -61.4 | |||||
Capital Expenditures, 2 Yr. CAGR % | -45.72 | -0.23 | 74.92 | 89.14 | -3.42 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 60.5 | 137.72 | 21.31 | 67.9 | 45.48 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -12.98 | 613.54 | 103.2 | 31.79 | -2.31 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | - | - | 79.78 | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -18.12 | 5.08 | 22.63 | 30.89 | 0.26 | |||||
Gross Profit, 3 Yr. CAGR % | -17.41 | 14.79 | 32.2 | 38.04 | -2.32 | |||||
EBITDA, 3 Yr. CAGR % | -47.16 | 19.28 | 67.66 | 118.8 | -15.02 | |||||
EBITA, 3 Yr. CAGR % | -15.12 | 46.66 | 109.88 | 45.17 | -26.54 | |||||
EBIT, 3 Yr. CAGR % | -2.9 | 58.47 | 62.81 | 26.85 | -41.4 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 30.71 | 16.19 | 17.51 | -13.44 | 0.98 | |||||
Net Income, 3 Yr. CAGR % | 22.82 | 21.98 | 12.82 | -10.81 | 15.62 | |||||
Normalized Net Income, 3 Yr. CAGR % | 27.81 | 49.83 | 5.32 | -11.75 | 15.59 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 29.87 | 24.82 | 12.09 | -14.88 | 16.07 | |||||
Accounts Receivable, 3 Yr. CAGR % | 3.36 | -0.01 | 8.59 | -3.36 | -6.13 | |||||
Inventory, 3 Yr. CAGR % | 0.54 | 7.45 | 15.98 | 10.52 | 1.54 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 0.69 | -4.33 | 2.19 | 5.42 | 6.16 | |||||
Total Assets, 3 Yr. CAGR % | 1.64 | 2.29 | 5.25 | 8.56 | 1.62 | |||||
Tangible Book Value, 3 Yr. CAGR % | -27.91 | -16.67 | 0.58 | 46.19 | 18.36 | |||||
Common Equity, 3 Yr. CAGR % | -10.39 | -8.33 | -0.11 | 24.18 | 9.69 | |||||
Cash From Operations, 3 Yr. CAGR % | 14.98 | 1.61 | 117.75 | 12.2 | -46.28 | |||||
Capital Expenditures, 3 Yr. CAGR % | -12.48 | -32.24 | 42.34 | 55.75 | 39.29 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 55.78 | 72.86 | 60.67 | 78.13 | 15.81 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 44.38 | 50.6 | 259.89 | 98.6 | -4.4 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | - | - | - | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -7.19 | 7.72 | 6.43 | 4.49 | 9.31 | |||||
Gross Profit, 5 Yr. CAGR % | -5.33 | 13.71 | 9.22 | 9.88 | 14.15 | |||||
EBITDA, 5 Yr. CAGR % | -18.44 | 27.04 | 12.59 | 15.25 | 15.56 | |||||
EBITA, 5 Yr. CAGR % | 91.22 | 64.85 | 17.75 | 34.91 | 16.42 | |||||
EBIT, 5 Yr. CAGR % | 49.42 | 38.96 | 18.89 | 41.57 | -13.72 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 90.23 | -0.92 | 19.69 | 11.47 | -2.12 | |||||
Net Income, 5 Yr. CAGR % | 129.4 | 0.53 | 15.88 | 15.44 | 4.33 | |||||
Normalized Net Income, 5 Yr. CAGR % | 31.68 | 11.02 | 16.54 | 31.11 | 0.89 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 137.03 | 1.43 | 17.03 | 16.52 | 4.18 | |||||
Accounts Receivable, 5 Yr. CAGR % | 6.01 | 3.35 | -0.7 | -3.01 | 4.96 | |||||
Inventory, 5 Yr. CAGR % | 7.22 | 8.76 | 5.91 | 6.77 | 8.5 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 0.75 | -0.84 | 3.8 | 1.23 | 2.12 | |||||
Total Assets, 5 Yr. CAGR % | 4.11 | 5.06 | 4.07 | 4.23 | 3.22 | |||||
Tangible Book Value, 5 Yr. CAGR % | -17.27 | -12.21 | -10.53 | 7.06 | 7.23 | |||||
Common Equity, 5 Yr. CAGR % | -7.19 | -2.95 | -2.64 | 5.63 | 3.95 | |||||
Cash From Operations, 5 Yr. CAGR % | -13.69 | 108.85 | 42.08 | -16.55 | 8.99 | |||||
Capital Expenditures, 5 Yr. CAGR % | -11.2 | -7.67 | 15.46 | 2.16 | 21.89 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 1.89 | 12.62 | 40.95 | 70.86 | 54.41 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -12.79 | 27.38 | 65.53 | 42.77 | 113.62 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | 18.75 | - | - |
- Stock Market
- Equities
- TUB Stock
- Financials Tubacex, S.A.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















